All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
Presence of abnormal karyotypes in essential thrombocythemia impacts fibrotic/leukemic progression and overall survival
Naseema Gangat and colleagues conducted a retrospective study to outline the prevalence and spectrum of cytogenetic abnormalities,...
Essential thrombocythemia with platelet count of 1.5 million
Naseema Gangat et al. conducted a retrospective study using a threshold of platelet count ≥1,500 × 109/L to define extreme thrombocytosis and estimate the prevalence of extreme...
"In the MPN Hub, we have gathered the most recent and most relevant information about MPN pathophysiology, clinical advances, and therapy. You are sure to find a response to your burning questions about MPN here!"
Are you a healthcare professional? What is your speciality?
Please select or type your speciality
By sharing this information, you can help ensure we continue to develop content that is of most relevance for our audience.
Thank you for submitting.